The effect of tilmicosin on fetal development in pregnant female rats was investigated in this study. Forty pregnant female rats were divided into four groups (each of 10 female rats). Rats in the 1st, 2nd and 3rd groups were received tilmicosin at a dose of 20, 100, 200 mg/kg · b · wt/day orally from the 6th to 15th day of gestation respectively, while the 4th group received 0.5 ml distilled water orally for the same period of gestation and was used as control group. All the pregnant female rats were sacrificed on the 20th day of gestation and their fetuses were subjected to morphological, visceral and skeletal examinations. Tilmicosin at a dose 100, 200 mg/kg · b · wt significantly decreased the number of viable fetuses; the number of resorbed fetuses was increased, and induced retardation in growth of viable fetuses; some skeletal and visceral defects in these fetuses were observed and these effects were dose dependant. It could be concluded that tilmicosin caused some abnormalities and fetal defects, so it is recommended to avoid using pregnancy.
KeywordsTilmicosinPregnancyAnomaliesFetus
Lin, K.J., Mitchell, A.A., Yau, W.P., Louik, C. and Hernández-Díaz, S. (2013) Safety of Macrolides during Pregnancy. American Journal of Obstetrics and Gynecology, 208, 221-228. http://dx.doi.org/10.1016/j.ajog.2012.12.023
Crider, K.S., Cleves, M.A., Reefhuis, J., Berry, R.J., Hobbs, C.A. and Hu, D.J. (2009) Antibacterial Medication Use during Pregnancy and Risk of Birth Defects: National Birth Defects Prevention Study. Archives of Pediatrics and Adolescent Medicine, 163, 978-985. http://dx.doi.org/10.1001/archpediatrics.2009.188
Mitchell, A.A., Gilboa, S.M., Werler, M.M., Kelley, K.E., Louik, C. and Hernandez, S.D. (2011) Medication Use during Pregnancy, with Particular Focus on Prescription Drugs: 1976-2008. American Journal of Obstetrics and Gynecology, 205, 51-58. http://dx.doi.org/10.1016/j.ajog.2011.02.029
Ose, E.E. and Tonkinson, L.V. (1988) Single-Dose Treatment of Neonatal Calf Pneumonia with the New Macrolide Antibiotic Tilmicosin. Veterinary Record, 123, 367-369. http://dx.doi.org/10.1136/vr.123.14.367
Gorham, P.E., Carroll, L.H., McAskill, J.W., Watkins, L.E., Ose, E.E., Tonkinson, L.V. and Merrill, J.K. (1990) Tilmicosin as a Single Injection Treatment for Respiratory Disease of Feedlot Cattle. Canadian Veterinary Journal, 31, 826-829.
Schumann, J.F., Janzen, E.D. and McKinnon, J.J. (1990) Prophylactic Tilmicosin Medication of Feedlot Calves at Arrival. Canadian Veterinary Journal, 31, 285-288.
Heikkinen, T., Laine, K., Neuvonen, P. and Ekblad, U. (2000) The Transplacental Transfer of the Macrolide Antibiotics Erythromycin, Roxithromycin and Azithromycin. International Journal of Obstetrics and Gynaecology, 107, 770-775. http://dx.doi.org/10.1111/j.1471-0528.2000.tb13339.x
Somer, G.F. (1962) Thalidomide and Congenital Abnormalities. The Lancet, 1, 912-913. http://dx.doi.org/10.1016/S0140-6736(62)91943-8
Rahilly, R.O. (2001) Human Embryology & Teratology. 3rd Edition, Wiley-Liss, New York.
Moore, K. (1988) The Developing Human. 4th Edition, WB Saunder, Philadelphia.
Hassert, G.L., De Baecke, P.J., Kulesza, J.S., Traina, V.M., Sinha, D.P. and Bernal, E. (1973) Toxicological, Pathological, and Teratological Studies in Animals with Cephradine. Antimicrobial Agents and Chemotherapy, 3, 682-685. http://dx.doi.org/10.1128/AAC.3.6.682
Macintyre, D.J., Chang, H.H. and Kaufman, M.H. (1995) Teratogenic Effects of Amniotic Sac Puncture: A Mouse Model. Journal of Anatomy, 186, 527-539.
Barcellona, P., Fanelli, O. and Campana, A. (1977) Teratological Study of Etoperidone in the Rat and Rabbi. Toxicology, 8, 87-94. http://dx.doi.org/10.1016/0300-483X(77)90026-9
Hayes, A.W. (1988) Principles and Method of Toxicology. 2nd Edition, Reven Press, New York.
Tuchmann, H. (1975) Drug Effects on Fetus. ADIS Press, New York.
Mossad, G.A.E.S., Ashraf, A.A.E.K. and Amany, A.A.E.M. (2014) Evaluation of Teratogenic Potentials and Tissue Residues of Tiamulin in Albino Rats. Nature and Science, 12, 100-105.
Zhu, J.B., Wan, X.Y., Zhu, Y.P., Ma, X.L., Zheng, Y.W. and Zhang, T.B. (2010) Toxicity of Bryostatin-1 on the Embryo Fetal Development of Sprague-Dawley Rats. Birth Defects Research Part B, Developmental and Reproductive Toxicology, 89, 171-174. http://dx.doi.org/10.1002/bdrb.20229
Noda, A. (1993) Teratogenicity Study of EL-870 (Tilmicosin Aqueous) in Rabbits by Gavage. Unpublished Study No. 91-001 from Research Institute for Animal Science in Biochemistry and Toxicology, Japan, Submitted to WHO by Lilly, Basingstoke, UK.
Karabulut, A.K., Uysal, I.I., Acar, H. and Fazliogullari, Z. (2008) Investigation of Developmental Toxicity and Teratogenicity of Macrolide Antibiotics in Cultured Rat Embryos. Anatomia, Histologia Embryologia, 37, 369-375. http://dx.doi.org/10.1111/j.1439-0264.2008.00861.x
Moriyama, Y., Ohata, Y., Mori, S., Matsukawa, S., Michiue, T., Asashima, M. and Kuroda, H. (2011) Rapamycin Treatment Causes Developmental Delay, Pigmentation Defects, and Gastrointestinal Malformation on Xenopus Embryogenesis. Biochemical and Biophysical Research Communications, 404, 974-978. http://dx.doi.org/10.1016/j.bbrc.2010.12.093
Wu, G., Meininger, C.J., Knabe, D.A., Bazer, F.W. and Rhoads, J.M. (2000) Arginine Nutrition in Development, Health and Disease. Current Opinion in Clinical Nutrition and Metabolic Care, 3, 59-66. http://dx.doi.org/10.1097/00075197-200001000-00010
Wu, G., Jaeger, L.A., Bazer, F.W. and Rhoads, J.M. (2004) Arginine Deficiency in Preterm Infants: Biochemical Mechanisms and Nutritional Implications. Journal of Nutritional Biochemistry, 15, 442-451. http://dx.doi.org/10.1016/j.jnutbio.2003.11.010
Christodoulopoulos, G. (2009) Adverse Outcome of Using Tilmicosin in a Lamb with Multiple Ventricular Septal Defects. Canadian Veterinary Journal, 50, 61-63.
Petrova, P. and Savitskaia, T.N. (1988) Prenatal Effect of Oleandomycin on the Development of the Immunogenesis Organs. Farmakologiia and Toksikologiia, 51, 85-86.
Kart, A., Yapar, K. and Karapehlivan M.M.C. (2007) The Possible Protective Effect of L-Carnitine on Tilmicosin-Induced Cardiotoxicity in Mice. Journal of Veterinary Medicine Series A-Physiology Pathology Clinical Medicine, 54, 144-146. http://dx.doi.org/10.1111/j.1439-0442.2007.00897.x
Takai, K., Jojima, K., Sakatoku, J. and Fukumoto, T. (1990) Effects of FK506 on Rat Thymus: Time-Course Analysis by Immunoperoxidase Technique and Flow Cytofluorometry. Clinical and Experimental Immunology, 82, 445-449. http://dx.doi.org/10.1111/j.1365-2249.1990.tb05469.x
Navarro, J.F., Mora, C., Jiménez, A., Torres, A., Macía, M. and García, J. (1999) Relationship between Serum Magnesium and Parathyroid Hormone Levels in Hemodialysis Patients. American Journal of Kidney Diseases, 34, 43-48. http://dx.doi.org/10.1016/S0272-6386(99)70106-X
Wei, M., Esbaei, K., Bargman, J. and Oreopoulos, D.G. (2006) Relationship between Serum Magnesium, Parathyroid Hormonr, and Vascular Calcification in Patients on Dialysis: A Literature Review. Peritoneal Dialysis International, 26, 366-373.
Phornphutkul, C., Lee, M., Voigt, C., Wu, K.Y., Ehrlich, M.G., Gruppuso, P.A. and Chen, Q. (2009) The Effect of Rapamycin on Bone Growth in Rabbits. Journal of Orthopeadic Research, 27, 1157-1161. http://dx.doi.org/10.1002/jor.20894